World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
29419
World Ranking
14982
National Ranking
791

Juris J. Meier publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Juris J. Meier sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 277 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Juris J. Meier D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Juris J. Meier sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Juris J. Meier is affiliated with Ruhr University Bochum in Germany and has contributed extensively to the field of medical research, focusing primarily on diabetes and metabolism. Their research encompasses several subfields, including endocrinology, molecular biology, surgery, pharmacology, and genetics.

Their work is mainly centered on the management and treatment of diabetes, with a particular emphasis on diabetes treatment and management, metabolism, and cancer, as well as pancreatic function related to diabetes. Other research topics covered include pharmacology and obesity treatment, diet and metabolism studies, and diabetes-associated disorders.

Notable recent publications by Juris J. Meier include:

  • Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation, 2021, Frontiers in Endocrinology
  • GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art, 2020, Molecular Metabolism
  • Treatment of type 2 diabetes: challenges, hopes, and anticipated successes, 2021, The Lancet Diabetes & Endocrinology
  • Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme, 2020, Diabetes Obesity and Metabolism
  • Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis, 2020, Diabetes Care

Juris J. Meier frequently collaborates with other researchers in the field. Notable coauthors include:

  • Michael A. Nauck
  • Daniel R. Quast
  • Richard E. Pratley
  • Christoph Kapitza
  • Nina Schenker

The researcher has published multiple papers in several key journals that focus on diabetes and metabolism. These venues include:

  • Diabetes Obesity and Metabolism
  • Diabetes
  • Diabetologie und Stoffwechsel
  • Diabetes Care
  • Experimental and Clinical Endocrinology & Diabetes

Juris J. Meier's work falls within the broader fields of medicine and biochemistry, genetics, and molecular biology, with the majority of publications contributing to medicine. Their research integrates clinical and molecular approaches to better understand and treat diabetes and associated metabolic disorders.

Best Publications

  • Glucagon-like peptide 1 (GLP-1)

    T.D. Müller;B. Finan;S.R. Bloom;D. D'Alessio

  • GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.

    Juris J. Meier

  • GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.

    Michael A. Nauck;Daniel R. Quast;Jakob Wefers;Juris J. Meier

  • β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

    Juris J. Meier;Alexandra E. Butler;Yoshifumi Saisho;Travis Monchamp

  • Incretin hormones: Their role in health and disease.

    Michael A. Nauck;Juris J. Meier

  • Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

    Michael A. Nauck;Stefano Del Prato;Juris J. Meier;Santiago Durán-García

  • Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

    Carolyn F. Deacon;Michael A. Nauck;Juris Meier;Katrin Hücking

  • Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

    J. J. Meier;A. Bhushan;A. E. Butler;R. A. Rizza

  • Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

    M. A. Nauck;I. Vardarli;C. F. Deacon;J. J. Holst

  • Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.

    Michael A. Nauck;Juris J. Meier;Matthew A. Cavender;Mirna Abd El Aziz

  • Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

    Y. Saisho;A. E. Butler;J. J. Meier;T. Monchamp

  • Normalization of Glucose Concentrations and Deceleration of Gastric Emptying after Solid Meals during Intravenous Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes

    Juris J. Meier;Baptist Gallwitz;Stefan Salmen;Oliver Goetze

  • PREDICTORS OF INCRETIN CONCENTRATIONS IN SUBJECTS WITH NORMAL, IMPAIRED, AND DIABETIC GLUCOSE TOLERANCE

    Kirsten Vollmer;Jens J. Holst;Birgit Baller;Mark Ellrichmann

  • The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions

    Michael A Nauck;Juris J Meier

  • Secretion, Degradation, and Elimination of Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide in Patients with Chronic Renal Insufficiency and Healthy Control Subjects

    Juris J. Meier;Michael A. Nauck;Daniel Kranz;Jens J. Holst

  • Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

    J. J. Meier;B. Gallwitz;N. Siepmann;J. J. Holst

  • Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

    Richard Pratley;Aslam Amod;Søren Tetens Hoff;Takashi Kadowaki

  • Glucagon‐like peptide 1(GLP‐1) in biology and pathology

    Juris J. Meier;Michael A. Nauck

  • Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans

    Michael A Nauck;Guido Kemmeries;Jens Juul Holst;Juris J Meier

  • Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans

    J. J. Meier;A. Gethmann;O. Götze;B. Gallwitz

Frequent Co-Authors

Michael A. Nauck
Michael A. Nauck Ruhr University Bochum
Jens J. Holst
Jens J. Holst University of Copenhagen
Carolyn F. Deacon
Carolyn F. Deacon University of Copenhagen
Peter C. Butler
Peter C. Butler University of California, Los Angeles
Andrea Tannapfel
Andrea Tannapfel Leipzig University
Robert A. Rizza
Robert A. Rizza Mayo Clinic
Michael Horowitz
Michael Horowitz University of Adelaide
Julio Rosenstock
Julio Rosenstock The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens the door to many alternative and related degree options beyond the traditional M.D. pathway. Today, flexible online programs make these opportunities more accessible than ever, allowing you to further your education while balancing work and life commitments.

For nursing professionals, advancing from registered nurse to nurse practitioner is a sought-after option. RN to NP bridge programs offer a streamlined path for those holding an associate’s degree, enabling career advancement into advanced practice roles. Alternatively, nurses looking to earn their bachelor’s without attending clinicals can explore RN to BSN programs no clinicals.

If you're interested in the intersection of healthcare and business, consider online MHA programs that prepare students for leadership roles in healthcare management. Or, if nutrition and wellness align more with your career goals, the best online nutrition degree programs open pathways to becoming a nutritionist or dietitian.

Each of these online degrees offers a unique career trajectory within healthcare, catering to diverse interests and helping fill critical roles in the industry.

Best Scientists Citing Juris J. Meier

Trending Scientists

Recently Published Articles